Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.44 |
| ▸ | GABRE | P78334 | 1/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.44 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.44 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.44 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27939140 | 0.85 | PBRM1 (0.45) | SLC6A2FNTAFNTBKMT2AMEN1 | |
| SCHEMBL28450714 | 0.83 | GPR84 (0.43) | SLC6A2FNTAFNTBGABRA1GABRB2 | |
| SCHEMBL7394209 | 0.83 | SLC6A2 (0.42) | SLC6A2FNTAFNTBGABRPGABRD | |
| SCHEMBL7609416 | 0.82 | SLC6A2 (0.41) | SLC6A2FNTAFNTBGABRPGABRD | |
| SCHEMBL8001498 | 0.81 | SLC6A2 (0.45) | SLC6A2FNTAFNTBGABRPGABRD | |
| SCHEMBL28686176 | 0.80 | MEN1 (0.49) | SLC6A2FNTAFNTBGABRPGABRD | |
| SCHEMBL3312775 | 0.80 | SLC6A2 (0.47) | SLC6A2FNTAFNTBGABRPGABRD | |
| SCHEMBL17866728 | 0.79 | PBRM1 (0.50) | KMT2AMEN1PBRM1MAPTKDM4E | |
| SCHEMBL7508029 | 0.78 | MEN1 (0.40) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6288556 | 0.77 | PBRM1 (0.49) | KMT2AMEN1PBRM1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000029022-A1 | COX-2 INHIBITORS IN COMBINATION WITH CENTRALLY ACTING ANALGESICS | ALGOS PHARMACEUTICAL CORPORATION (US) | 2000-05-25 | — | — | WO | claimed |
| WO-2016164593-A1 | COMPOSITIONS AND METHODS FOR MODULATING HYDROXYLATION OF ACC2 BY PHD3 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-10-13 | — | — | WO | disclosed |
| EP-2147315-A2 | DIABETES-RELATED BIOMARKERS AND METHODS OF USE THEREOF | Tethys Bioscience, Inc. (US) | 2010-01-27 | — | — | EP | disclosed |
| EP-2001496-A4 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL (US) | 2009-07-08 | — | — | EP | disclosed |
| EP-2001496-A2 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | The Brigham & Women's Hospital, Inc. (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2008131224-A2 | DIABETES-RELATED BIOMARKERS AND METHODS OF USE THEREOF | TETHYS BIOSCIENCE, INC. (US) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008048607-A2 | COLLAGEN PEPTIDES AS IMMUNE MODULATORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-04-24 | — | — | WO | disclosed |
| WO-2007136674-A9 | DETECTION AND MONITORING OF LIVER DAMAGE | CLEVELAND CLINIC FOUNDATION (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2007136674-A1 | DETECTION AND MONITORING OF LIVER DAMAGE | THE CLEVELAND CLINIC FOUNDATION (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007109056-A2 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| WO-2005055810-A2 | RISK MARKERS FOR CARDIOVASCULAR DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2005-06-23 | — | — | WO | disclosed |
| EP-1191929-A4 | (Z)-STYRYL ACETOXYPHENYL SULFIDES AS CYCLOOXYGENASE INHIBITORS | UNIV TEMPLE (US) | 2005-02-16 | — | — | EP | disclosed |
| EP-1451577-A2 | SOLUBLE CD40L(CD154) AS A PROGNOSTIC MARKER OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003040691-A2 | SOLUBLE CD40L(CD154) AS A PROGNOSTIC MARKER OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2003-05-15 | — | — | WO | disclosed |
| EP-1191931-A4 | 1-(4-SULFAMYLARYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | UNIV TEMPLE (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1191931-A1 | 1-(4-SULFAMYLARYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | Temple University of the Commonwealth System of Higher Education (US) | 2002-04-03 | — | — | EP | disclosed |
| EP-1191929-A2 | (Z)-STYRYL ACETOXYPHENYL SULFIDES AS CYCLOOXYGENASE INHIBITORS | Temple University of the Commonwealth System of Higher Education (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000077169-A2 | (Z)-STYRYL ACETOXYPHENYL SULFIDES AS CYCLOOXYGENASE INHIBITORS | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000076503-A1 | 1-(4-SULFAMYLARYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000076983-A1 | 1-(4-ARYLSULFONYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2000-12-21 | — | — | WO | disclosed |